HEADER HYDROLASE/HYDROLASE INHIBITOR 07-NOV-04 1XXP TITLE YERSINIA YOPH (RESIDUES 163-468) C403S BINDS PHOSPHOTYROSYL PEPTIDE AT TITLE 2 TWO SITES COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN-TYROSINE PHOSPHATASE YOPH; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: CATALYTIC DOMAIN, RESIDUES 163-468; COMPND 5 SYNONYM: VIRULENCE PROTEIN; COMPND 6 EC: 3.1.3.48; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: HEXAPEPTIDE ASP-ALA-ASP-GLU-PTR-CLE; COMPND 11 CHAIN: C, D, E, F; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: YERSINIA ENTEROCOLITICA; SOURCE 3 ORGANISM_TAXID: 630; SOURCE 4 GENE: YOPH, YOP51; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21/DE3; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PT7-7; SOURCE 10 MOL_ID: 2; SOURCE 11 SYNTHETIC: YES; SOURCE 12 OTHER_DETAILS: THE PEPTIDE WAS CHEMICALLY SYNTHESIZED. KEYWDS PEPTIDE BINDS AT SITE REMOTE FROM CATALYTIC SITE. IMPORTANT FOR KEYWDS 2 PROTEIN LOCALIZATION IN INFECTED CELL., HYDROLASE, HYDROLASE- KEYWDS 3 HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR M.I.IVANOV,J.A.STUCKEY,H.L.SCHUBERT,M.A.SAPER,J.B.BLISKA REVDAT 7 20-NOV-24 1XXP 1 REMARK REVDAT 6 15-NOV-23 1XXP 1 REMARK REVDAT 5 23-AUG-23 1XXP 1 REMARK REVDAT 4 20-OCT-21 1XXP 1 DBREF SEQADV LINK REVDAT 3 13-JUL-11 1XXP 1 VERSN REVDAT 2 24-FEB-09 1XXP 1 VERSN REVDAT 1 22-MAR-05 1XXP 0 JRNL AUTH M.I.IVANOV,J.A.STUCKEY,H.L.SCHUBERT,M.A.SAPER,J.B.BLISKA JRNL TITL TWO SUBSTRATE-TARGETING SITES IN THE YERSINIA PROTEIN JRNL TITL 2 TYROSINE PHOSPHATASE CO-OPERATE TO PROMOTE BACTERIAL JRNL TITL 3 VIRULENCE JRNL REF MOL.MICROBIOL. V. 55 1346 2005 JRNL REFN ISSN 0950-382X JRNL PMID 15720545 JRNL DOI 10.1111/J.1365-2958.2005.04477.X REMARK 2 REMARK 2 RESOLUTION. 3.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 10084 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.181 REMARK 3 FREE R VALUE : 0.250 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 534 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4497 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 83 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 24.40 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.177 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : ISOTROPIC REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: RESTRAINED B REFINEMENT REMARK 4 REMARK 4 1XXP COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 24-NOV-04. REMARK 100 THE DEPOSITION ID IS D_1000030886. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 298 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : MONOCHROMATOR REMARK 200 REMARK 200 DETECTOR TYPE : AREA DETECTOR REMARK 200 DETECTOR MANUFACTURER : UCSD MARK III REMARK 200 INTENSITY-INTEGRATION SOFTWARE : SDMS REMARK 200 DATA SCALING SOFTWARE : SDMS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 10084 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.000 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 86.0 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.11800 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: PDB ENTRY 1YTS REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.73 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.27 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10-12 MG/ML PROTEIN + 1 MM REMARK 280 PHOSPHOPEPTIDE. PRECIPITANT: 18-24% POLYETHYLENE GLYCOL (PEG) REMARK 280 8000, 50-100 MM NACL, 0.1% BETA-MERCAPTOETHANOL, 100 MM TRISCL, REMARK 280 PH 8.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1450 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12640 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -10.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1430 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12500 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -10.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PRO A 163 REMARK 465 ARG A 164 REMARK 465 GLU A 165 REMARK 465 ARG A 166 REMARK 465 PRO A 167 REMARK 465 HIS A 168 REMARK 465 THR A 169 REMARK 465 SER A 170 REMARK 465 GLY A 171 REMARK 465 HIS A 172 REMARK 465 HIS A 173 REMARK 465 GLY A 174 REMARK 465 ALA A 175 REMARK 465 GLY A 176 REMARK 465 GLU A 177 REMARK 465 ALA A 178 REMARK 465 ARG A 179 REMARK 465 ALA A 180 REMARK 465 THR A 181 REMARK 465 PRO B 163 REMARK 465 ARG B 164 REMARK 465 GLU B 165 REMARK 465 ARG B 166 REMARK 465 PRO B 167 REMARK 465 HIS B 168 REMARK 465 THR B 169 REMARK 465 SER B 170 REMARK 465 GLY B 171 REMARK 465 HIS B 172 REMARK 465 HIS B 173 REMARK 465 GLY B 174 REMARK 465 ALA B 175 REMARK 465 GLY B 176 REMARK 465 GLU B 177 REMARK 465 ALA B 178 REMARK 465 ARG B 179 REMARK 465 ALA B 180 REMARK 465 THR B 181 REMARK 465 ALA B 182 REMARK 465 PRO B 183 REMARK 465 SER B 184 REMARK 465 THR B 185 REMARK 465 ACE C 100 REMARK 465 ASP C 101 REMARK 465 ACE D 100 REMARK 465 ASP D 101 REMARK 465 ALA D 102 REMARK 465 ASP D 103 REMARK 465 GLU D 104 REMARK 465 LEU D 106 REMARK 465 NH2 D 107 REMARK 465 ACE E 100 REMARK 465 ASP E 101 REMARK 465 ACE F 100 REMARK 465 ASP F 101 REMARK 465 ALA F 102 REMARK 465 ASP F 103 REMARK 465 GLU F 104 REMARK 465 LEU F 106 REMARK 465 NH2 F 107 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 183 -98.76 -55.72 REMARK 500 SER A 184 74.98 -178.65 REMARK 500 VAL A 186 22.36 40.47 REMARK 500 SER A 187 75.96 -178.69 REMARK 500 ILE A 232 78.91 -102.29 REMARK 500 ARG A 236 -70.73 -76.77 REMARK 500 GLN A 237 49.46 -71.24 REMARK 500 THR A 238 -11.37 -168.01 REMARK 500 THR A 318 -111.26 -126.53 REMARK 500 ASP A 325 16.09 56.08 REMARK 500 PRO A 355 176.20 -54.27 REMARK 500 GLN A 357 16.78 58.94 REMARK 500 SER A 403 -110.99 -108.12 REMARK 500 ASN A 424 51.61 -96.82 REMARK 500 GLN A 426 -9.81 84.77 REMARK 500 ARG A 440 -69.04 -142.14 REMARK 500 VAL A 445 66.05 64.83 REMARK 500 GLN A 446 -70.82 -58.48 REMARK 500 ASN A 467 -165.08 -102.97 REMARK 500 ILE B 232 78.74 -103.21 REMARK 500 ARG B 236 -70.92 -75.76 REMARK 500 GLN B 237 49.07 -71.44 REMARK 500 THR B 238 -10.68 -167.28 REMARK 500 THR B 318 -111.97 -125.36 REMARK 500 ASP B 325 16.07 56.08 REMARK 500 PRO B 355 175.25 -54.69 REMARK 500 GLN B 357 16.74 58.91 REMARK 500 SER B 403 -110.49 -107.41 REMARK 500 ASN B 424 51.16 -96.28 REMARK 500 GLN B 426 -10.21 85.76 REMARK 500 ARG B 440 -69.65 -143.05 REMARK 500 VAL B 445 67.23 64.89 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN C OF HEXAPEPTIDE ASP-ALA REMARK 800 -ASP-GLU-PTR-CLE REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN D OF HEXAPEPTIDE ASP-ALA REMARK 800 -ASP-GLU-PTR-CLE REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN E OF HEXAPEPTIDE ASP-ALA REMARK 800 -ASP-GLU-PTR-CLE REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN F OF HEXAPEPTIDE ASP-ALA REMARK 800 -ASP-GLU-PTR-CLE REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1XXV RELATED DB: PDB REMARK 900 COMPANION STRUCTURE OF ACTIVE YOPH BOUND TO A PHOSPHOTYROSYL REMARK 900 MIMETIC HEXAPEPTIDE REMARK 900 RELATED ID: 1QZ0 RELATED DB: PDB REMARK 900 LIKE 1XXV BUT FROM OTHER RESEARCHERS DBREF 1XXP A 163 468 UNP P15273 YOPH_YEREN 163 468 DBREF 1XXP B 163 468 UNP P15273 YOPH_YEREN 163 468 DBREF 1XXP C 100 107 PDB 1XXP 1XXP 100 107 DBREF 1XXP D 100 107 PDB 1XXP 1XXP 100 107 DBREF 1XXP E 100 107 PDB 1XXP 1XXP 100 107 DBREF 1XXP F 100 107 PDB 1XXP 1XXP 100 107 SEQADV 1XXP ARG A 235 UNP P15273 CYS 235 ENGINEERED MUTATION SEQADV 1XXP SER A 403 UNP P15273 CYS 403 ENGINEERED MUTATION SEQADV 1XXP ARG B 235 UNP P15273 CYS 235 ENGINEERED MUTATION SEQADV 1XXP SER B 403 UNP P15273 CYS 403 ENGINEERED MUTATION SEQRES 1 A 306 PRO ARG GLU ARG PRO HIS THR SER GLY HIS HIS GLY ALA SEQRES 2 A 306 GLY GLU ALA ARG ALA THR ALA PRO SER THR VAL SER PRO SEQRES 3 A 306 TYR GLY PRO GLU ALA ARG ALA GLU LEU SER SER ARG LEU SEQRES 4 A 306 THR THR LEU ARG ASN THR LEU ALA PRO ALA THR ASN ASP SEQRES 5 A 306 PRO ARG TYR LEU GLN ALA CYS GLY GLY GLU LYS LEU ASN SEQRES 6 A 306 ARG PHE ARG ASP ILE GLN CYS ARG ARG GLN THR ALA VAL SEQRES 7 A 306 ARG ALA ASP LEU ASN ALA ASN TYR ILE GLN VAL GLY ASN SEQRES 8 A 306 THR ARG THR ILE ALA CYS GLN TYR PRO LEU GLN SER GLN SEQRES 9 A 306 LEU GLU SER HIS PHE ARG MET LEU ALA GLU ASN ARG THR SEQRES 10 A 306 PRO VAL LEU ALA VAL LEU ALA SER SER SER GLU ILE ALA SEQRES 11 A 306 ASN GLN ARG PHE GLY MET PRO ASP TYR PHE ARG GLN SER SEQRES 12 A 306 GLY THR TYR GLY SER ILE THR VAL GLU SER LYS MET THR SEQRES 13 A 306 GLN GLN VAL GLY LEU GLY ASP GLY ILE MET ALA ASP MET SEQRES 14 A 306 TYR THR LEU THR ILE ARG GLU ALA GLY GLN LYS THR ILE SEQRES 15 A 306 SER VAL PRO VAL VAL HIS VAL GLY ASN TRP PRO ASP GLN SEQRES 16 A 306 THR ALA VAL SER SER GLU VAL THR LYS ALA LEU ALA SER SEQRES 17 A 306 LEU VAL ASP GLN THR ALA GLU THR LYS ARG ASN MET TYR SEQRES 18 A 306 GLU SER LYS GLY SER SER ALA VAL ALA ASP ASP SER LYS SEQRES 19 A 306 LEU ARG PRO VAL ILE HIS SER ARG ALA GLY VAL GLY ARG SEQRES 20 A 306 THR ALA GLN LEU ILE GLY ALA MET CYS MET ASN ASP SER SEQRES 21 A 306 ARG ASN SER GLN LEU SER VAL GLU ASP MET VAL SER GLN SEQRES 22 A 306 MET ARG VAL GLN ARG ASN GLY ILE MET VAL GLN LYS ASP SEQRES 23 A 306 GLU GLN LEU ASP VAL LEU ILE LYS LEU ALA GLU GLY GLN SEQRES 24 A 306 GLY ARG PRO LEU LEU ASN SER SEQRES 1 B 306 PRO ARG GLU ARG PRO HIS THR SER GLY HIS HIS GLY ALA SEQRES 2 B 306 GLY GLU ALA ARG ALA THR ALA PRO SER THR VAL SER PRO SEQRES 3 B 306 TYR GLY PRO GLU ALA ARG ALA GLU LEU SER SER ARG LEU SEQRES 4 B 306 THR THR LEU ARG ASN THR LEU ALA PRO ALA THR ASN ASP SEQRES 5 B 306 PRO ARG TYR LEU GLN ALA CYS GLY GLY GLU LYS LEU ASN SEQRES 6 B 306 ARG PHE ARG ASP ILE GLN CYS ARG ARG GLN THR ALA VAL SEQRES 7 B 306 ARG ALA ASP LEU ASN ALA ASN TYR ILE GLN VAL GLY ASN SEQRES 8 B 306 THR ARG THR ILE ALA CYS GLN TYR PRO LEU GLN SER GLN SEQRES 9 B 306 LEU GLU SER HIS PHE ARG MET LEU ALA GLU ASN ARG THR SEQRES 10 B 306 PRO VAL LEU ALA VAL LEU ALA SER SER SER GLU ILE ALA SEQRES 11 B 306 ASN GLN ARG PHE GLY MET PRO ASP TYR PHE ARG GLN SER SEQRES 12 B 306 GLY THR TYR GLY SER ILE THR VAL GLU SER LYS MET THR SEQRES 13 B 306 GLN GLN VAL GLY LEU GLY ASP GLY ILE MET ALA ASP MET SEQRES 14 B 306 TYR THR LEU THR ILE ARG GLU ALA GLY GLN LYS THR ILE SEQRES 15 B 306 SER VAL PRO VAL VAL HIS VAL GLY ASN TRP PRO ASP GLN SEQRES 16 B 306 THR ALA VAL SER SER GLU VAL THR LYS ALA LEU ALA SER SEQRES 17 B 306 LEU VAL ASP GLN THR ALA GLU THR LYS ARG ASN MET TYR SEQRES 18 B 306 GLU SER LYS GLY SER SER ALA VAL ALA ASP ASP SER LYS SEQRES 19 B 306 LEU ARG PRO VAL ILE HIS SER ARG ALA GLY VAL GLY ARG SEQRES 20 B 306 THR ALA GLN LEU ILE GLY ALA MET CYS MET ASN ASP SER SEQRES 21 B 306 ARG ASN SER GLN LEU SER VAL GLU ASP MET VAL SER GLN SEQRES 22 B 306 MET ARG VAL GLN ARG ASN GLY ILE MET VAL GLN LYS ASP SEQRES 23 B 306 GLU GLN LEU ASP VAL LEU ILE LYS LEU ALA GLU GLY GLN SEQRES 24 B 306 GLY ARG PRO LEU LEU ASN SER SEQRES 1 C 8 ACE ASP ALA ASP GLU PTR LEU NH2 SEQRES 1 D 8 ACE ASP ALA ASP GLU PTR LEU NH2 SEQRES 1 E 8 ACE ASP ALA ASP GLU PTR LEU NH2 SEQRES 1 F 8 ACE ASP ALA ASP GLU PTR LEU NH2 MODRES 1XXP PTR C 105 TYR O-PHOSPHOTYROSINE MODRES 1XXP PTR D 105 TYR O-PHOSPHOTYROSINE MODRES 1XXP PTR E 105 TYR O-PHOSPHOTYROSINE MODRES 1XXP PTR F 105 TYR O-PHOSPHOTYROSINE HET PTR C 105 16 HET NH2 C 107 1 HET PTR D 105 16 HET PTR E 105 16 HET NH2 E 107 1 HET PTR F 105 16 HETNAM PTR O-PHOSPHOTYROSINE HETNAM NH2 AMINO GROUP HETSYN PTR PHOSPHONOTYROSINE FORMUL 3 PTR 4(C9 H12 N O6 P) FORMUL 3 NH2 2(H2 N) FORMUL 7 HOH *83(H2 O) HELIX 1 1 GLY A 190 LEU A 208 1 19 HELIX 2 2 GLN A 266 ASN A 277 1 12 HELIX 3 3 SER A 287 ASN A 293 1 7 HELIX 4 4 SER A 361 LYS A 386 1 26 HELIX 5 5 SER A 388 ASP A 393 5 6 HELIX 6 6 GLY A 408 ASN A 420 1 13 HELIX 7 7 SER A 428 ARG A 440 1 13 HELIX 8 8 LYS A 447 GLY A 460 1 14 HELIX 9 9 GLY B 190 LEU B 208 1 19 HELIX 10 10 GLN B 266 ASN B 277 1 12 HELIX 11 11 SER B 287 ASN B 293 1 7 HELIX 12 12 SER B 361 LYS B 386 1 26 HELIX 13 13 SER B 388 ASP B 393 5 6 HELIX 14 14 GLY B 408 ASN B 420 1 13 HELIX 15 15 SER B 428 GLN B 439 1 12 HELIX 16 16 LYS B 447 GLN B 461 1 15 SHEET 1 A 8 ALA A 246 VAL A 251 0 SHEET 2 A 8 THR A 254 CYS A 259 -1 O ALA A 258 N ASN A 247 SHEET 3 A 8 VAL A 400 HIS A 402 1 O ILE A 401 N ILE A 257 SHEET 4 A 8 LEU A 282 VAL A 284 1 N ALA A 283 O VAL A 400 SHEET 5 A 8 ILE A 344 VAL A 351 1 O VAL A 349 N LEU A 282 SHEET 6 A 8 MET A 328 GLU A 338 -1 N TYR A 332 O VAL A 348 SHEET 7 A 8 ILE A 311 VAL A 313 -1 N THR A 312 O ARG A 337 SHEET 8 A 8 GLY A 306 TYR A 308 -1 N TYR A 308 O ILE A 311 SHEET 1 B 7 ALA A 246 VAL A 251 0 SHEET 2 B 7 THR A 254 CYS A 259 -1 O ALA A 258 N ASN A 247 SHEET 3 B 7 VAL A 400 HIS A 402 1 O ILE A 401 N ILE A 257 SHEET 4 B 7 LEU A 282 VAL A 284 1 N ALA A 283 O VAL A 400 SHEET 5 B 7 ILE A 344 VAL A 351 1 O VAL A 349 N LEU A 282 SHEET 6 B 7 MET A 328 GLU A 338 -1 N TYR A 332 O VAL A 348 SHEET 7 B 7 MET A 317 GLY A 322 -1 N THR A 318 O MET A 331 SHEET 1 C 8 ALA B 246 VAL B 251 0 SHEET 2 C 8 THR B 254 CYS B 259 -1 O ALA B 258 N ASN B 247 SHEET 3 C 8 VAL B 400 HIS B 402 1 O ILE B 401 N ILE B 257 SHEET 4 C 8 LEU B 282 VAL B 284 1 N ALA B 283 O VAL B 400 SHEET 5 C 8 ILE B 344 VAL B 351 1 O VAL B 349 N LEU B 282 SHEET 6 C 8 MET B 328 GLU B 338 -1 N TYR B 332 O VAL B 348 SHEET 7 C 8 ILE B 311 VAL B 313 -1 N THR B 312 O ARG B 337 SHEET 8 C 8 GLY B 306 TYR B 308 -1 N TYR B 308 O ILE B 311 SHEET 1 D 7 ALA B 246 VAL B 251 0 SHEET 2 D 7 THR B 254 CYS B 259 -1 O ALA B 258 N ASN B 247 SHEET 3 D 7 VAL B 400 HIS B 402 1 O ILE B 401 N ILE B 257 SHEET 4 D 7 LEU B 282 VAL B 284 1 N ALA B 283 O VAL B 400 SHEET 5 D 7 ILE B 344 VAL B 351 1 O VAL B 349 N LEU B 282 SHEET 6 D 7 MET B 328 GLU B 338 -1 N TYR B 332 O VAL B 348 SHEET 7 D 7 MET B 317 GLY B 322 -1 N THR B 318 O MET B 331 LINK C GLU C 104 N PTR C 105 1555 1555 1.33 LINK C PTR C 105 N LEU C 106 1555 1555 1.32 LINK C GLU E 104 N PTR E 105 1555 1555 1.33 LINK C PTR E 105 N LEU E 106 1555 1555 1.32 SITE 1 AC1 12 ARG A 278 ARG A 295 LYS A 342 THR A 343 SITE 2 AC1 12 SER A 345 MET A 382 TYR A 383 LYS A 386 SITE 3 AC1 12 SER A 388 SER A 389 HOH C 88 HOH C 90 SITE 1 AC2 11 PHE A 229 ASP A 356 GLN A 357 SER A 403 SITE 2 AC2 11 ARG A 404 ALA A 405 GLY A 406 VAL A 407 SITE 3 AC2 11 GLY A 408 ARG A 409 GLN A 446 SITE 1 AC3 12 SER A 468 ARG B 278 ARG B 295 LYS B 342 SITE 2 AC3 12 THR B 343 SER B 345 MET B 382 TYR B 383 SITE 3 AC3 12 LYS B 386 SER B 388 SER B 389 HOH E 91 SITE 1 AC4 12 PHE B 229 ASP B 231 ASP B 356 GLN B 357 SITE 2 AC4 12 SER B 403 ARG B 404 ALA B 405 GLY B 406 SITE 3 AC4 12 VAL B 407 GLY B 408 ARG B 409 GLN B 446 CRYST1 54.170 71.090 47.860 111.80 90.00 109.70 P 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018460 0.006610 0.002837 0.00000 SCALE2 0.000000 0.014941 0.006414 0.00000 SCALE3 0.000000 0.000000 0.022738 0.00000